Colorectal Cancer - Pipeline Review, H1 2016 - Global Markets Direct - Market Research

Colorectal Cancer - Pipeline Review, H1 2016

Colorectal Cancer - Pipeline Review, H1 2016 - Global Markets Direct - Market Research
Colorectal Cancer - Pipeline Review, H1 2016
Published Jun 30, 2016
1564 pages — Published Jun 30, 2016
Price US$ 2,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Colorectal Cancer - Pipeline Review, H1 2016, provides an overview of the Colorectal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Colorectal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Colorectal Cancer and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Colorectal Cancer
- The report reviews pipeline therapeutics for Colorectal Cancer by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Colorectal Cancer therapeutics and enlists all their major and minor projects
- The report assesses Colorectal Cancer therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Colorectal Cancer

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Colorectal Cancer
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Colorectal Cancer pipeline depth and focus of Indication th

  
Source:
Document ID
GMDHC7959IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents256
  List of Tables507
  List of Figures571
Introduction581
  Global Markets Direct Report Coverage581
Colorectal Cancer Overview591
Therapeutics Development602
  Pipeline Products for Colorectal Cancer Overview601
  Pipeline Products for Colorectal Cancer Comparative Analysis611
Colorectal Cancer Therapeutics under Development by Companies6220
Colorectal Cancer Therapeutics under Investigation by Universities/Institutes822
Colorectal Cancer Pipeline Products Glance844
  Late Stage Products841
  Clinical Stage Products851
  Early Stage Products861
  Unknown Stage Products871
Colorectal Cancer Products under Development by Companies8827
Colorectal Cancer Products under Investigation by Universities/Institutes1153
Colorectal Cancer Companies Involved in Therapeutics Development118227
  2cureX ApS1181
  3-V Biosciences, Inc.1191
  4SC AG1201
  AB Science SA1211
  AbbVie Inc.1221
  AbGenomics International, Inc.1231
  Actinium Pharmaceuticals, Inc.1241
  Adamed Sp. z o.o.1251
  Advaxis, Inc.1261
  Advenchen Laboratories, LLC1271
  Alchemia Limited1281
  Allinky Biopharma1291
  Amal Therapeutics SA1301
  Amgen Inc.1311
  Antibe Therapeutics, Inc.1321
  Apac Biotech Pvt Ltd1331
  Apexigen, Inc.1341
  Aphios Corporation1351
  Aposense Ltd.1361
  Arisaph Pharmaceuticals, Inc.1371
  ArQule, Inc.1381
  Array BioPharma Inc.1391
  Astellas Pharma Inc.1401
  Astex Pharmaceuticals, Inc.1411
  AstraZeneca Plc1421
  ATLAB Pharma SAS1431
  AVEO Pharmaceuticals, Inc.1441
  Basilea Pharmaceutica AG1451
  Bavarian Nordic A/S1461
  Bayer AG1471
  BeiGene, Ltd.1481
  Biocon Limited1491
  Bionomics Limited1501
  Bionovis SA1511
  Biotecnol, Inc.1521
  Boehringer Ingelheim GmbH1531
  Boston Biomedical, Inc.1541
  Bristol-Myers Squibb Company1551
  Burzynski Research Institute, Inc.1561
  Calithera Biosciences, Inc.1571
  Carna Biosciences, Inc.1581
  Cascadian Therapeutics Inc1591
  CCRP Therapeutics GmbH1601
  Celator Pharmaceuticals, Inc.1611
  Celgene Corporation1621
  Cellceutix Corporation1631
  Celldex Therapeutics, Inc.1641
  Cellectar Biosciences, Inc.1651
  Celltrion, Inc.1661
  Chiome Bioscience, Inc.1671
  Chipscreen Biosciences Ltd1681
  Cipla Ltd.1691
  Cleave Biosciences1701
  Cleveland BioLabs, Inc.1711
  Clonz Biotech Private Limited1721
  Coare Biotechnology, Inc.1731
  Coherus BioSciences, Inc.1741
  Cornerstone Pharmaceuticals, Inc.1751
  Corvus Pharmaceuticals, Inc.1761
  Critical Outcome Technologies Inc.1771
  CritiTech, Inc.1781
  CrystalGenomics, Inc.1791
  Cytune Pharma SAS1801
  Daiichi Sankyo Company, Limited1811
  DanDrit Biotech A/S1821
  Deciphera Pharmaceuticals, LLC1831
  Delcath Systems, Inc.1841
  Dicerna Pharmaceuticals, Inc.1851
  Digna Biotech, S.L.1861
  Double Bond Pharmaceutical International AB1871
  Dr. Reddy's Laboratories Limited1881
  EirGenix Inc.1891
  Eisai Co., Ltd.1901
  Eli Lilly and Company1911
  Endor Nanotechnologies SL1921
  enGene, Inc1931
  EnGeneIC Ltd1941
  Ensol Biosciences Inc.1951
  EntreChem, S.L.1961
  Enzo Biochem, Inc.1971
  Etubics Corporation1981
  Exelixis, Inc.1991
  F. Hoffmann-La Roche Ltd.2001
  Five Prime Therapeutics, Inc.2011
  Fusion Antibodies Limited2021
  Gene Techno Science Co., Ltd.2032
  Genor BioPharma Co., Ltd.2051
  Genoscience Pharma2061
  Genzyme Corporation2071
  Gilead Sciences, Inc.2081
  GlaxoSmithKline Plc2091
  Glycotope GmbH2101
  Golden Biotechnology Corp.2111
  Green Cross Corporation2121
  Hadasit Medical Research Services &Development Ltd2131
  Hanmi Pharmaceuticals, Co. Ltd.2141
  Heat Biologics, Inc.2151
  Hemispherx Biopharma, Inc.2161
  Hetero Drugs Limited2171
  Hutchison MediPharma Limited2181
  iDD biotech SAS2191
  Ideaya Biosciences Inc2201
  Ignyta, Inc.2211
  Immatics Biotechnologies GmbH2221
  Immodulon Therapeutics Ltd.2231
  ImmuneXcite, Inc.2241
  Immunomedics, Inc.2251
  Immunovative Therapies, Ltd.2261
  Incanthera Ltd.2271
  Incyte Corporation2281
  Innovent Biologics, Inc.2291
  Inovio Pharmaceuticals, Inc.2301
  Interprotein Corporation2311
  Ionis Pharmaceuticals, Inc.2321
  Isofol Medical AB2331
  ISU ABXIS Co.,Ltd.2341
  Jeil Pharmaceutical Co., Ltd.2351
  JHL Biotech, Inc.2361
  Jiangsu Hengrui Medicine Co., Ltd.2371
  Johnson &Johnson2381
  KaloBios Pharmaceuticals, Inc.2391
  Kancera AB2401
  Karyopharm Therapeutics, Inc.2411
  Kolltan Pharmaceuticals, Inc.2421
  Kura Oncology, Inc.2431
  Laboratorio ELEA S.A.C.I.F. y A.2441
  Lee's Pharmaceutical Holdings Limited2451
  Loxo Oncology, Inc.2461
  Mabion SA2471
  Mabtech Limited2481
  mAbxience S.A.2491
  MacroGenics, Inc.2501
  MediaPharma s.r.l.2511
  MedImmune, LLC2521
  Medinet Co., Ltd.2531
  Medivation, Inc.2541
  Merck &Co., Inc.2551
  Merck KGaA2561
  Merrimack Pharmaceuticals, Inc.2571
  Merus B.V.2581
  Mirna Therapeutics, Inc.2591
  MolMed S.p.A.2601
  Mologen AG2611
  Momenta Pharmaceuticals, Inc.2621
  Morphotek, Inc.2631
  Multimmune GmbH2641
  Mycenax Biotech Inc.2651
  Natco Pharma Limited2661
  NatureWise Biotech &Medicals Corporation2671
  Nektar Therapeutics2681
  Neovacs SA2691
  Nerviano Medical Sciences S.r.l.2701
  Nippon Kayaku Co., Ltd.2711
  NormOxys, Inc.2721
  Northwest Biotherapeutics, Inc.2731
  Novartis AG2741
  NuCana BioMed Limited2751
  OBI Pharma, Inc.2761
  Oncobiologics, Inc.2771
  Oncolytics Biotech Inc.2781
  OncoMed Pharmaceuticals, Inc.2791
  Onconova Therapeutics, Inc.2801
  Ono Pharmaceutical Co., Ltd.2811
  Oryx GmbH &Co. KG2821
  Otsuka Holdings Co., Ltd.2831
  Oxford BioMedica Plc2841
  Panacea Biotec Limited2851
  Pfizer Inc.2861
  Pharma Mar, S.A.2871
  PharmAbcine, Inc.2881
  Pharmacyclics, Inc.2891
  Pivot Pharmaceuticals Inc2901
  Pivotal BioSciences, Inc.2911
  Plexxikon Inc.2921
  PLx Pharma Inc.2931
  Precision Biologics, Inc.2941
  Provectus Biopharmaceuticals, Inc.2951
  PsiOxus Therapeutics Limited2961
  Puma Biotechnology, Inc.2971
  Quimatryx, S.L.2981
  R-Pharm2991
  RedHill Biopharma Ltd.3001
  Redx Pharma Plc3011
  Reliance Life Sciences Pvt. Ltd.3021
  Rexahn Pharmaceuticals, Inc.3031
  Rgenix, Inc.3041
  Richter Gedeon Nyrt.3051
  Sanofi3061
  Selvita S.A.3071
  Shanghai Henlius Biotech Co., Ltd.3081
  Shire Plc3091
  Sigma-Tau S.p.A.3101
  Sigmoid Pharma Limited3111
  Sihuan Pharmaceutical Holdings Group Ltd.3121
  Sillajen Biotherapeutics3131
  Sirnaomics, Inc.3141
  Snowdon Inc.3151
  Solvotrin Therapeutics Limited3161
  Sorrento Therapeutics, Inc.3171
  Sumitomo Dainippon Pharma Co., Ltd.3181
  SuviCa Inc.3191
  Symphogen A/S3201
  Synermore Biologics Co Ltd3211
  Taiho Pharmaceutical Co., Ltd.3221
  TaiwanJ Pharmaceuticals Co., Ltd.3231
  Takis S.r.l.3241
  Tara Immuno-Oncology Therapeutics LLC3251
  Targovax AS3261
  TetraLogic Pharmaceuticals3271
  Teva Pharmaceutical Industries Ltd.3281
  TG Therapeutics, Inc.3291
  Theravectys SA3301
  Tiltan Pharma Ltd.3311
  Tocagen Inc.3321
  TRACON Pharmaceuticals, Inc.3331
  Transgene SA3341
  United BioPharma, Inc.3351
  Vaccinex, Inc.3361
  VasGene Therapeutics, Inc.3371
  Vaximm AG3381
  Vertex Pharmaceuticals Incorporated3391
  ViiV Healthcare Limited3401
  Viralytics Ltd.3411
  Wilex AG3421
  WntResearch AB3431
  XBiotech USA, Inc.3441
Colorectal Cancer Therapeutics Assessment34544
  Assessment by Monotherapy Products3451
  Assessment by Combination Products3461
  Assessment by Target34719
  Assessment by Mechanism of Action36619

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Colorectal Cancer - Pipeline Review, H1 2016" Jun 30, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Colorectal-Cancer-Pipeline-Review-H1-2016-2088-16063>
  
APA:
Global Markets Direct - Market Research. (2016). Colorectal Cancer - Pipeline Review, H1 2016 Jun 30, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Colorectal-Cancer-Pipeline-Review-H1-2016-2088-16063>
  
US$ 2,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.